Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-05

Clinical Trial Update: A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial comparing telmisartan/hydrochlorothiazide against valsartan/hydrochlorothiazide in patients with stage I/II hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diovan HCT (valsartan/hydrochlorothiazide)
  • MICARDIS HCT (Telmisartan and hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 4 | Status: COMPLETED